Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees

Karrer

Ben Karrer, Kalamazoo, MI US

Patent application number	Description	Published
20090192019	FOUNDATION BRAKE HILL START AIDE SYSTEM - An exemplary embodiment of a Hill Start Aide system for a vehicle includes a brake system. The brake system including a brake actuator for manually actuating the brake system. The brake system is selectively configurable in a stopped configuration, where the brake system is manually maintained via the brake actuator such that a vehicle road wheel speed is about zero rpm, a released configuration, where the brake system will not generally inhibit rotation of at least one vehicle road wheel, and a control stop configuration, where the vehicle road wheel speed is about zero rpm. The Hill Start Aide system also includes a controller for at least partially controlling the brake system. The controller will selectively send a signal to maintain the brake system in the control stopped configuration when the brake actuator is manually released. The controller will send a signal to the brake system to release the brakes when a predetermined amount of time has elapsed after a transmission is manually shifted to a neutral configuration while the brake system is in the control stopped configuration.	07-30-2009

Erik Karrer, Fremont, CA US

Patent application number	Description	Published
20080207459	ANTIBODY DIVERSITY GENERATION - Methods for improving antibodies by a variety of DNA diversification and selection procedures are provided. Improvements include increases in affinity, alterations in specificity and effector function, as well as reduced antigenicity, e.g. humanization. Libraries of recombinant antibody sequences are provided, as are cells expressing members of such libraries. Novel phage display vectors are provided. Methods for the coevolution of an antibody and its cognate antigen are provided. Coevolution is used to evolve HIV envelope proteins with increased antigenicity and broadly neutralizing antibodies that interact therewith. Methods of improving antibodies for use in the detection of biological warfare agents are provided.	08-28-2008

Erik Karrer, Mountain View, CA US

Patent application number	Description	Published
20120135912	POLYPEPTIDE INHIBITORS OF VLA4 - The invention provides novel 2D-VCAM-1 variant polypeptides and conjugates thereof that bind human VLA4. The invention also provides related polynucleotides, compositions, vectors, host cells, and methods.	05-31-2012

Erik E. Karrer, Mountain View, CA US

Patent application number	Description	Published
20090258031	IMMUNOSUPPRESSIVE POLYPEPTIDES AND NUCLEIC ACIDS - The invention provides immunosuppressive polypeptides and nucleic acids encoding such polypeptides. In one aspect, the invention provides mutant CTLA-4 polypeptides and nucleic acids encoding mutant CTLA-4 polypeptides. Compositions and methods for utilizing such polypeptides and nucleic acids are also provided.	10-15-2009
20100260759	IMMUNOSUPPRESSIVE POLYPEPTIDES AND NUCLEIC ACIDS - The invention provides immunosuppressive polypeptides and nucleic acids encoding such polypeptides. In one aspect, the invention provides mutant CTLA-4 polypeptides and nucleic acids encoding mutant CTLA-4 polypeptides. Compositions and methods for utilizing such polypeptides and nucleic acids are also provided.	10-14-2010
20110129875	IMMUNOSUPPRRESSIVE POLYPEPTIDES AND NUCLEIC ACIDS - The invention provides immunosuppressive polypeptides and nucleic acids encoding such polypeptides. In one aspect, the invention provides mutant CTLA-4 polypeptides and nucleic acids encoding mutant CTLA-4 polypeptides. Compositions and methods for utilizing such polypeptides and nucleic acids are also provided.	06-02-2011
20110130546	IMMUNOSUPPRESSIVE POLYPEPTIDES AND NUCLEIC ACIDS - The invention provides immunosuppressive polypeptides and nucleic acids encoding such polypeptides. In one aspect, the invention provides mutant CTLA-4 polypeptides and nucleic acids encoding mutant CTLA-4 polypeptides. Compositions and methods for utilizing such polypeptides and nucleic acids are also provided.	06-02-2011
20110159542	IMMUNOSUPPRESSIVE POLYPEPTIDES AND NUCLEIC ACIDS - The invention provides immunosuppressive polypeptides and nucleic acids encoding such polypeptides. In one aspect, the invention provides mutant CTLA-4 polypeptides and nucleic acids encoding mutant CTLA-4 polypeptides. Compositions and methods for utilizing such polypeptides and nucleic acids are also provided.	06-30-2011
20110166324	IMMUNOSUPPRESSIVE POLYPEPTIDES AND NUCLEIC ACIDS - The invention provides immunosuppressive polypeptides and nucleic acids encoding such polypeptides. In one aspect, the invention provides mutant CTLA-4 polypeptides and nucleic acids encoding mutant CTLA-4 polypeptides. Compositions and methods for utilizing such polypeptides and nucleic acids are also provided.	07-07-2011
20110177071	IMMUNOSUPPRESSIVE POLYPEPTIDES AND NUCLEIC ACIDS - The invention provides immunosuppressive polypeptides and nucleic acids encoding such polypeptides. In one aspect, the invention provides mutant CTLA-4 polypeptides and nucleic acids encoding mutant CTLA-4 polypeptides. Compositions and methods for utilizing such polypeptides and nucleic acids are also provided.	07-21-2011
20110182898	IMMUNOSUPPRESSIVE POLYPEPTIDES AND NUCLEIC ACIDS - The invention provides immunosuppressive polypeptides and nucleic acids encoding such polypeptides. In one aspect, the invention provides mutant CTLA-4 polypeptides and nucleic acids encoding mutant CTLA-4 polypeptides. Compositions and methods for utilizing such polypeptides and nucleic acids are also provided.	07-28-2011

Heinrich Karrer, Regau AT

Patent application number	Description	Published
20090266593	SURFACE-MOUNTABLE ELECTRONIC DEVICE - A surface-mountable electronic device free of leads has a plurality of solderable connection surfaces at its lower side, with at least one of the connection surfaces having a rectangular portion. The outline of this rectangular portion corresponds to a connection surface of the JEDEC Standard MO-236 or of any other standard according to which the respective connection surface should not extend directly up to a side edge of the lower device side. The at least one connection surface furthermore has an extension section which extends, starting from the rectangular portion, in the direction of a side edge of the lower side of the device.	10-29-2009

Karin Karrer, Pfeffingen CH

Patent application number	Description	Published
20080295733	Preparations of Pteridine Pigments - The present invention relates to a pigment preparation that comprises, as component (A), 2,4,5,7-tetraminopyrimido[5,4g]pteridine of formula (1), as component (B), a phosphate compound, and optionally, as component (C), further additives, to a process for the production thereof and to the use thereof for colouring high molecular weight organic material and in the production of printing colorants, printing pastes or printing inks.	12-04-2008
20110118384	PEARLESCENT PIGMENTS COATED WITH A METAL OXIDE/HYDROXIDE LAYER AND AN ACRYLIC COPOLYMER - The invention relates to pearlescent pigments comprising a platelet-shaped substrate, a metal oxide coating comprising a metal oxide layer having a refractive index of greater than 1.8 and a protective layer, wherein the protective layer comprises a metal oxide/hydroxide layer and optionally boroxide, applied to which is an organic aftercoat of an acrylic copolymer, to a method for producing said pigments and the use thereof. The outer layer provides a very good photo-stabilisation of the TiO	05-19-2011